Required support to avoid batch rejection due to poor assay performance

  • A vaccine manufacturer produced a bulk drug Substance (DS)
  • Dilution with a formulation buffer is made to obtain a Drug Product ready to be filled in syringes
  • However, the titration of biologic material is subject to large uncertainty due to poor assay performance, leading to frequent and costly batch rejection